EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…
BETHESDA, Md., Nov. 9, 2025 /PRNewswire/ -- Marriott International, Inc. (NASDAQ: MAR) today announced that its licensing agreement with Sonder…
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…
Agora and Akool integrate real-time conversational AI with lifelike streaming avatars to elevate interactive experiences across voice, video, and chat.…
CINCINNATI--(BUSINESS WIRE)--Fifth Third Private Bank, a division of Fifth Third Bank (Nasdaq: FITB), is pleased to announce its second consecutive…
With Sale of EPIC Crude, Y-Grade and Olefins Businesses in Last 10 Months, EPIC Has Now Driven Gross Transaction Value…
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter…
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…